The secondary immune selection is the dominant mechanism for acquired resistance against adoptive cell therapy

被引:0
|
作者
Kamada, Takahiro [1 ]
Togashi, Yosuke [1 ]
Ohue, Yoshihiro [1 ]
Nishikawa, Hiroyoshi [1 ]
机构
[1] Natl Canc Ctr, Kashiwa, Chiba, Japan
关键词
D O I
10.1158/1538-7445.SABCS18-2308
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2308
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Adoptive T-cell therapy: a need for standard immune monitoring
    Klaver, Yarne
    Kunert, Andre
    Sleijfer, Stefan
    Debets, Reno
    Lamers, Cor H. J.
    IMMUNOTHERAPY, 2015, 7 (05) : 513 - 533
  • [22] Vector-free engineering of immune cells for adoptive cell therapy
    Sharei, Armon
    Gilbert, Jonathan
    Irvine, Darrell
    Jensen, Klays
    Langer, Robert
    CANCER RESEARCH, 2016, 76
  • [23] Primary and Acquired Resistance against Immune Check Inhibitors in Non-Small Cell Lung Cancer
    Sun, Qinying
    Wei, Xiangzhen
    Wang, Zhonglin
    Zhu, Yan
    Zhao, Weiying
    Dong, Yuchao
    CANCERS, 2022, 14 (14)
  • [24] ADOPTIVE CELL THERAPY AGAINST DIPG USING DEVELOPMENTALLY REGULATED ANTIGENS
    Flores, Catherine
    Gil, Jorge
    Abraham, Rebecca
    Pham, Christina
    Wildes, Tyler
    Moore, Ginger
    Drake, Jeffrey
    Dyson, Kyle
    Mitchell, Duane
    NEURO-ONCOLOGY, 2017, 19 : 32 - 32
  • [25] Acquired BRAF fusions as a mechanism of resistance to EGFR therapy.
    Vojnic, Morana
    Kurzatkowski, Christopher
    Kubota, Daisuke
    Suzawa, Ken
    Liu, Zebing
    Mattar, Marissa
    Khodos, Inna
    Poirier, John T.
    de Stanchina, Elisa
    Rudin, Charles M.
    Riely, Gregory J.
    Yu, Helena Alexandra
    Arcila, Maria E.
    Ladanyi, Marc
    Somwar, Romel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Immunomodulation on tumor immune microenvironment in acquired targeted therapy resistance and implication for immunotherapy resistance
    Chou, Ming-Yu
    Yang, Muh-Hwa
    TRANSLATIONAL ONCOLOGY, 2025, 54
  • [27] Elimination of resident macrophages from the livers and spleens of immune mice impairs acquired resistance against a secondary Listeria monocytogenes infection
    Samsom, JN
    Annema, A
    Groeneveld, PHP
    vanRooijen, N
    Langermans, JAM
    vanFurth, R
    INFECTION AND IMMUNITY, 1997, 65 (03) : 986 - 993
  • [28] Is Adoptive Cellular Therapy With Non-T-Cell Immune Effectors the Future?
    Ali, Alaa Kassim
    Tarannum, Mubin
    Romee, Rizwan
    CANCER JOURNAL, 2021, 27 (02): : 168 - 175
  • [29] Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy
    Kodumudi, Krithika N.
    Siegel, Jessica
    Weber, Amy M.
    Scott, Ellen
    Sarnaik, Amod A.
    Pilon-Thomas, Shari
    PLOS ONE, 2016, 11 (04):
  • [30] Adoptive Immune-Cell Therapy for the Treatment of Neuroendocrine Carcinoma of the Uterine Cervix
    Goto, Shigenori
    Terao, Yasuhisa
    Kamigaki, Takashi
    Takimoto, Rishu
    Naitoh, Keiko
    Makita, Kaori
    Yasumoto, Kosei
    Okada, Sachiko
    Takizawa, Ken
    Yokomichi, Noriyuki
    Suzuki, Nao
    Takeda, Satoru
    ANTICANCER RESEARCH, 2020, 40 (08) : 4741 - 4748